单细胞追踪揭示黑色素瘤 TIL 治疗过程中肿瘤反应性 T 细胞的可塑性
Single-cell tracking reveals tumor-reactive T cell plasticity during melanoma TIL therapy.
TIL(肿瘤浸润淋巴细胞)过继细胞治疗可在转移性黑色素瘤中诱导持久缓解,然而在体外扩增过程中及回输后,调控肿瘤反应性T细胞命运的克隆和转录动态仍知之甚少。
英文原题:Clinical Correlation of Function and TCR vβ Diversity of MAGE-C2-Specific CD8(+) T Cell Response in Esophageal Cancer.
这些结果提示,功能性MAGE-C2特异性CD8+ T细胞的存在对食管癌患者的生存具有独立预后影响。
黑色素瘤相关抗原(MAGE)-C2是一种免疫原性癌症生殖系(睾丸)抗原,在多种肿瘤细胞、胸腺髓质上皮细胞和生殖细胞中高表达。本研究旨在探讨MAGE-C2特异性CD8+ T细胞的免疫学特性及其TCR β链V区(TCR vβ)亚家族分布与食管癌患者预后的关系。经CD3/CD28 Dynabeads和MAGE-C2肽体外扩增的PBMC和TIL(肿瘤浸润淋巴细胞),可诱导MAGE-C2特异性CD8+ T细胞表面表达溶酶体相关膜蛋白-1(LAMP-1或CD107a)并产生IFN-γ。我们发现,流式分选的CD107a+IFN-γ+与CD107a−IFN-γ−CD8+ T细胞之间TCR vβ亚家族分布存在差异。在淋巴结转移、肿瘤晚期和低分化状态的患者中,CD107a+和/或IFN-γ+四聚体+CD8+ T细胞比例较低(p < 0.05)。T-box转录因子与CD107a和IFN-γ呈正相关。Kaplan-Meier分析显示,与MAGE-C2特异性CD8+ T细胞低表达CD107a和/或IFN-γ的患者相比,高表达CD107a和/或IFN-γ的患者生存时间更长。此外,TCR vβ亚家族分布分析显示,MAGE-C2特异性CD8+ T细胞中TCR vβ16频率较高与更好的预后呈正相关。这些结果表明,功能性MAGE-C2特异性CD8+ T细胞的存在对食管癌患者的生存具有独立预后影响。
Melanoma-associated Ag (MAGE)-C2, an immunogenic cancer germline (testis) Ag, is highly expressed by various tumor cells, thymic medullary epithelial cells, and germ cells. In this study, we aimed to explore the immunologic properties of MAGE-C2-specific CD8 + T cells and the relationship of its TCR β-chain V region (TCR vβ) subfamily distribution to prognosis of patients with esophageal cancer. PBMCs and tumor-infiltrating lymphocytes expanded by CD3/CD28 Dynabeads and MAGE-C2 peptides in vitro resulted in the induction of lysosome-associated membrane protein-1 (LAMP-1 or CD107a) on the cell surface and the production of IFN-γ by MAGE-C2-specific CD8 + T cells. We found differential TCR vβ subfamily distribution among flow-sorted CD107a + IFN-γ + and CD107a - IFN-γ - CD8 + T cells. The proportion of CD107a + and/or IFN-γ + tetramer + CD8 + T cells was lower in patients with lymph node metastasis, late tumor stage, and poorly differentiated state ( p < 0.05). T-box transcription factor was positively correlated with CD107a and IFN-γ. Kaplan-Meier analysis showed that patients whose MAGE-C2-specific CD8 + T cells expressed high CD107a and/or IFN-γ had a longer survival time when compared with patients whose MAGE-C2-specific CD8 + T cells expressed low levels of CD107a and/or IFN-γ. Moreover, analysis of TCR vβ subfamily distribution revealed that a higher frequency of TCR vβ16 in MAGE-C2-specific CD8 + T cells was positively correlated with a better prognosis. These results suggest that the presence of functional MAGE-C2-specific CD8 + T cells had an independent prognostic impact on the survival of patients with esophageal cancer.
MEMBER ACCOUNT
登录成功会直接打开下一页。